BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11879140)

  • 1. Hyperfractionated external beam radiation therapy in the treatment of murine transgenic retinoblastoma.
    Hayden BC; Murray TG; Cicciarelli N; Scott IU; Alexandridou A; Hernandez E; Wu X; Markoe AM; Feuer W; Fulton L; O'Brien JM
    Arch Ophthalmol; 2002 Mar; 120(3):353-9. PubMed ID: 11879140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External beam radiation "salvage" therapy in transgenic murine retinoblastoma.
    Sobrin L; Hayden BC; Murray TG; Cicciarelli N; Scott IU; Hernandez E; Wu X; Markoe AM; Feuer W; Fulton L; O'Brien JM
    Arch Ophthalmol; 2004 Feb; 122(2):251-7. PubMed ID: 14769602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation therapy and ferromagnetic hyperthermia in the treatment of murine transgenic retinoblastoma.
    Murray TG; O'Brien JM; Steeves RA; Smith BJ; Albert DM; Cicciarelli N; Markoe AM; Tompkins DT; Windle JJ
    Arch Ophthalmol; 1996 Nov; 114(11):1376-81. PubMed ID: 8906028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local carboplatin and radiation therapy in the treatment of murine transgenic retinoblastoma.
    Murray TG; Roth DB; O'Brien JM; Feuer W; Cicciarelli N; Markoe AM; Hernández E; Smith BJ; Windle JJ
    Arch Ophthalmol; 1996 Nov; 114(11):1385-9. PubMed ID: 8906029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of external beam radiation therapy for retinoblastoma after failure of combined chemoreduction and focal consolidation therapy.
    Yousef YA; Mohammad M; Jaradat I; Shatnawi R; Banat S; Mehyar M; Al-Nawaiseh I
    Ophthalmic Genet; 2020 Feb; 41(1):20-25. PubMed ID: 32072842
    [No Abstract]   [Full Text] [Related]  

  • 6. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.
    Jockovich ME; Suarez F; Alegret A; Piña Y; Hayden B; Cebulla C; Feuer W; Murray TG
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5371-6. PubMed ID: 18055783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular preservation after 36 Gy external beam radiation therapy for retinoblastoma.
    Merchant TE; Gould CJ; Hilton NE; Kun LE; Rodríguez-Galindo C; Pratt CB; Wilson MW; Haik B
    J Pediatr Hematol Oncol; 2002 May; 24(4):246-9. PubMed ID: 11972090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External beam radiation for retinoblastoma: results, patterns of failure, and a proposal for treatment guidelines.
    Hernandez JC; Brady LW; Shields JA; Shields CL; DePotter P; Karlsson UL; Markoe AM; Amendola BE; Singh A
    Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):125-32. PubMed ID: 8641908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combretastatin A-4 prodrug in the treatment of a murine model of retinoblastoma.
    Escalona-Benz E; Jockovich ME; Murray TG; Hayden B; Hernandez E; Feuer W; Windle JJ
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):8-11. PubMed ID: 15623747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
    Rodriguez-Galindo C; Wilson MW; Haik BG; Merchant TE; Billups CA; Shah N; Cain A; Langston J; Lipson M; Kun LE; Pratt CB
    J Clin Oncol; 2003 May; 21(10):2019-25. PubMed ID: 12743157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation.
    Chan MP; Hungerford JL; Kingston JE; Plowman PN
    Br J Ophthalmol; 2009 Jul; 93(7):891-4. PubMed ID: 19329423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma.
    Murray TG; Cicciarelli N; O'Brien JM; Hernández E; Mueller RL; Smith BJ; Feuer W
    Arch Ophthalmol; 1997 Oct; 115(10):1286-90. PubMed ID: 9338675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy.
    Sussman DA; Escalona-Benz E; Benz MS; Hayden BC; Feuer W; Cicciarelli N; Toledano S; Markoe A; Murray TG
    Arch Ophthalmol; 2003 Jul; 121(7):979-84. PubMed ID: 12860801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The modern role of radiation therapy in treating advanced-stage retinoblastoma: long-term outcomes and racial differences.
    Orman A; Koru-Sengul T; Miao F; Markoe A; Panoff JE
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1037-43. PubMed ID: 25442037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subconjunctival carboplatin in retinoblastoma: impact of tumor burden and dose schedule.
    Hayden BH; Murray TG; Scott IU; Cicciarelli N; Hernandez E; Feuer W; Fulton L; O'Brien JM
    Arch Ophthalmol; 2000 Nov; 118(11):1549-54. PubMed ID: 11074812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of retinoblastoma with radiation.
    Lal P; Biswal BM; Mohanti BK; Rath GK; Ghose S; Vasantha T; Sharma DN; Arya LS
    Indian Pediatr; 2001 Jan; 38(1):15-23. PubMed ID: 11175929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pars plana lensectomy and intraocular lens implantation in pediatric radiation-induced cataracts in retinoblastoma.
    Miller DM; Murray TG; Cicciarelli NL; Capo H; Markoe AM
    Ophthalmology; 2005 Sep; 112(9):1620-4. PubMed ID: 16024083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.